Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 25, 2026 | CMS / Medicare | MolDX: MGMT Promoter Methylation Analysis | Codes changed |
| May 25, 2026 | CMS / Medicare | Nerve Blockade for Treatment of Chronic Pain and Neuropathy | Codes changed |
| May 25, 2026 | CMS / Medicare | Botulinum Toxin Type A & Type B | Codes changed |
| May 25, 2026 | CMS / Medicare | Immune Globulin Intravenous (IVIg) | Codes changed |
| May 25, 2026 | CMS / Medicare | B-type Natriuretic Peptide (BNP) Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | Botulinum Toxins | Codes changed |
| May 25, 2026 | CMS / Medicare | Botulinum Toxins | Codes changed |
| May 25, 2026 | CMS / Medicare | Chemodenervation | Codes changed |
| May 25, 2026 | CMS / Medicare | Brain Natriuretic Peptide (BNP) Level | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Molecular Pathology Procedures | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Bevacizumab and biosimilars | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Polysomnography and Other Sleep Studies | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Polysomnography and Other Sleep Studies | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Tremor | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Botulinum Toxin Injections | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Intraosseous Basivertebral Nerve Ablation | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Sacroiliac Joint Injections and Procedures | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Spinraza (nusinersen) | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Facet Joint Interventions for Pain Management | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Transurethral Waterjet Ablation of the Prostate | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | Billing and Coding: MolDX: Pigmented Lesion Assay | Codes changed |